SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-16-014851
Filing Date
2016-11-14
Accepted
2016-11-14 10:53:37
Documents
46
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 373339
2 ex31-1.htm EX-31.1 8615
3 ex32-1.htm EX-32.1 4622
4 image_001.jpg GRAPHIC 7255
  Complete submission text file 0001493152-16-014851.txt   2201519

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE endv-20160930.xml EX-101.INS 326982
6 XBRL SCHEMA FILE endv-20160930.xsd EX-101.SCH 26145
7 XBRL CALCULATION FILE endv-20160930_cal.xml EX-101.CAL 38377
8 XBRL DEFINITION FILE endv-20160930_def.xml EX-101.DEF 110072
9 XBRL LABEL FILE endv-20160930_lab.xml EX-101.LAB 205576
10 XBRL PRESENTATION FILE endv-20160930_pre.xml EX-101.PRE 166879
Mailing Address 6320 CANOGA AVENUE 15TH FLOOR WOODLAND HILLS CA 91367
Business Address 6320 CANOGA AVENUE 15TH FLOOR WOODLAND HILLS CA 91367 (800) 489-4774
ENDONOVO THERAPEUTICS, INC. (Filer) CIK: 0001528172 (see all company filings)

IRS No.: 452552528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55453 | Film No.: 161991990
SIC: 2834 Pharmaceutical Preparations